News tagged with cell institute
New model of childhood brain cancer establishes first step to personalized treatment
Scientists at Sanford-Burnham Medical Research Institute (Sanford-Burnham) developed a new mouse model for studying a devastating childhood brain cancer called medulloblastoma. The animal model mimics the ...
9 hours ago |
5 / 5 (1) |
0
|
First prospective clinical trial of adaptive radiotherapy for head and neck cancer patients
Researchers led by a senior investigator at Hofstra-North Shore LIJ School of Medicine and The Feinstein Institute for Medical Research have released initial findings from a first-of-a-kind clinical trial in adaptive radiotherapy ...
Feb 09, 2012 |
5 / 5 (1) |
0
Study identifies new prostate cancer drug target
Research led by Wanguo Liu, PhD, Associate Professor of Genetics at LSU Health Sciences Center New Orleans, has identified a new protein critical to the development and growth of prostate cancer. The findings are published ...
Feb 06, 2012 |
5 / 5 (1) |
0
|
FDA clears Pfizer drug for advanced kidney cancer
(AP) -- The Food and Drug Administration has approved a new Pfizer drug for patients with advanced kidney cancer that has spread to other parts of the body despite treatment with at least one previous drug.
Medicine & Health / Medications
Jan 27, 2012 |
5 / 5 (2) |
0
Lead blood levels may increase smokers' risk for kidney cancer
Higher than normal levels of lead in the blood may signal a risk two times higher than average of developing renal cell carcinoma in smokers, according to medical researchers.
Jan 23, 2012 |
not rated yet |
0
|
Novel treatment for skin lymphoma
Promising findings on a novel combination treatment approach for a chronic type of skin lymphoma are being published today (embargoed for 4 pm) in JAMA's Archives of Dermatology by clinical researchers from Seidman Cancer ...
Jan 17, 2012 |
5 / 5 (1) |
0
Autologous stem cell transplantation does not improve os in patients with follicular lymphoma
High-dose chemotherapy and autologous stem cell transplantation (HDC-ASCT), for previously untreated patients with advanced follicular lymphoma (FL) does not improve overall survival compared with conventional-dose chemotherapy ...
Dec 21, 2011 |
not rated yet |
0
Soybean compounds enhances effects of cancer radiotherapy
A Wayne State University researcher has shown that compounds found in soybeans can make radiation treatment of lung cancer tumors more effective while helping to preserve normal tissue.
Dec 19, 2011 |
not rated yet |
0
Advantages and motivations uncertain behind use of brachytherapy for breast cancer radiotherapy
Accelerated partial breast irradiation using brachytherapy (APBIb) for the treatment of breast cancer has been rapidly increasing over the last several years in the U.S. as an alternative to standard whole-breast irradiation ...
Dec 16, 2011 |
not rated yet |
0
AML patients have high response rate with vorinostat added to treatment
Adding a drug that activates genes to frontline combination therapy for acute myeloid leukemia resulted in an 85 percent remission rate after initial treatment, researchers at The University of Texas MD Anderson Cancer Center ...
Dec 13, 2011 |
not rated yet |
0
B cell receptor inhibitor causes chronic lymphocytic leukemia remission
A new, targeted approach to treating chronic lymphocytic leukemia has produced durable remissions in a Phase I/II clinical trial for patients with relapsed or resistant disease, investigators report at the 53rd Annual Meeting ...
Dec 11, 2011 |
5 / 5 (2) |
0
Tumor-targeting compound points the way to new personalized cancer treatments
One major obstacle in the fight against cancer is that anticancer drugs often affect normal cells in addition to tumor cells, resulting in significant side effects. Yet research into development of less harmful treatments ...
Dec 01, 2011 |
not rated yet |
0
|
Researchers shrink tumors, minimize side effects using tumor-homing peptide to deliver treatment
The trouble with most anti-cancer therapies is that they are lethal to most cells in the body, not just cancer cells. As a result, patients experience side effects like nausea, increased susceptibility to ...
Nov 21, 2011 |
5 / 5 (5) |
1
|
Mitochondria restructuring protein provides new therapeutic target for heart disease
Mitochondria are often called cellular "powerhouses" because they convert nutrients into energy. But these tiny structures also help determine cellular lifespan. Scientists at Sanford-Burnham Medical Research ...
Medicine & Health / Cardiology
Nov 17, 2011 |
5 / 5 (2) |
0
|
Folate receptors may serve as a front door to ovarian cancer treatment
A new strategy that takes advantage of ovarian cancer's reliance on folate appears to give relapse patients extra months of life with few side effects, researchers say.
Oct 28, 2011 |
5 / 5 (1) |
0
|
